Showing results (631-640 of 651) with videos related to

Sort By:
Pageof 66
Pharmacoepidemiology and Drug Safety|November 4, 2020
Incorporating patient generated health data into pharmacoepidemiological researchAlison Bourke, William G Dixon, Andrew Roddam, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2000
The discovery and synthesis of highly potent, A2a receptor agonistsS E Keeling, F D Albinson, B E Ayres, et al.
Blood|May 25, 2013
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyDavid M Ross, Susan Branford, John F Seymour, et al.
Skeletal Radiology|June 12, 2026
Standardized MRI nomenclature for knee meniscal lesions: SSR consensus panel reportJie C Nguyen, Tetyana Gorbachova, Dyan V Flores, et al.
Scientific Reports|July 26, 2018
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanomaH Halse, A J Colebatch, P Petrone, et al.
The Journal of Clinical Investigation|February 7, 2017
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacyPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Nature Materials|April 4, 2018
Collapse of superconductivity in cuprates via ultrafast quenching of phase coherenceF Boschini, E H da Silva Neto, E Razzoli, et al.
Pathology|September 17, 2011
Mobilisation strategies for normal and malignant cellsL Bik To, Jean-Pierre Levesque, Kirsten E Herbert, et al.
BMJ Open|January 18, 2024
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trialsZoe McQuilten, Stephane Heritier, Lucy Fox, et al.
Leukemia|October 14, 2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsDavid M Ross, Ilaria S Pagani, Naranie Shanmuganathan, et al.
Pageof 66